LOBULAR CARCINOMA IN SITU
Clinical trials for LOBULAR CARCINOMA IN SITU explained in plain language.
Never miss a new study
Get alerted when new LOBULAR CARCINOMA IN SITU trials appear
Sign up with your email to follow new studies for LOBULAR CARCINOMA IN SITU, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot aims to stop breast cancer before it starts
Disease control Not yet recruitingThis early-phase trial tests a drug called CAN1012 in 24 people with pre-cancerous breast conditions (DCIS or LCIS). The drug is injected directly into the lesion to activate the immune system. The main goal is to check safety and ensure the treatment doesn't delay necessary surg…
Matched conditions: LOBULAR CARCINOMA IN SITU
Phase: PHASE1 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Surgery-free breast cancer treatment tested in new trial
Disease control Not yet recruitingThis study is testing whether people with certain non-invasive or early breast conditions (like ductal carcinoma in situ) can safely skip surgery and instead take hormone-blocking medication. The goal is to see if this approach keeps cancer from coming back over five years. The t…
Matched conditions: LOBULAR CARCINOMA IN SITU
Phase: NA • Sponsor: Jeong Eon Lee • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Could a 'Baby Dose' of hormone pills prevent breast cancer?
Prevention Not yet recruitingThis study tests whether low doses of two hormone-blocking drugs, exemestane and tamoxifen, can help prevent breast cancer in postmenopausal women at high risk. About 140 women will take one of the two drugs for a year, and researchers will measure side effects and quality of lif…
Matched conditions: LOBULAR CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Prevention
Last updated Jun 27, 2026 12:01 UTC